Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Public Health Nursing (Boston, Mass.)|February 5, 2020
Development of a telehealth intervention to promote care-seeking among transgender women of color in Washington, DCManya Magnus, Elizabeth Edwards, Aurnell Dright, et al.
Open Forum Infectious Diseases|February 27, 2018
Sexually Transmitted Infections Among HIV-Infected Individuals in the District of Columbia and Estimated HIV Transmission Risk: Data From the DC CohortJose Lucar, Rachel Hart, Nabil Rayeed, et al.
BMC Bioinformatics|August 6, 2014
Clinical PathoScope: rapid alignment and filtration for accurate pathogen identification in clinical samples using unassembled sequencing dataAllyson L Byrd, Joseph F Perez-Rogers, Solaiappan Manimaran, et al.
Research Square|August 16, 2024
Dual role of circulating and mucosal Vδ1 T cells in the control of and contribution to persistent HIV-1 infectionBrendan T Mann, Marta Sanz, Matthew Clohosey, et al.
Nature Communications|July 2, 2025
Dual role of circulating and mucosal Vδ1 T cells in the control of and contribution to persistent HIV-1 infectionBrendan T Mann, Marta Sanz, Matthew L Clohosey, et al.
Open Forum Infectious Diseases|September 9, 2020
Impact of Infectious Disease Consultation in Patients With Candidemia: A Retrospective Study, Systematic Literature Review, and Meta-analysisTakaaki Kobayashi, Alexandre R Marra, Marin L Schweizer, et al.
AIDS and Behavior|February 14, 2020
Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077Elizabeth E Tolley, Sahar Z Zangeneh, Gordon Chau, et al.
Antimicrobial Agents and Chemotherapy|April 26, 2017
Evaluation of a Multidrug Assay for Monitoring Adherence to a Regimen for HIV Preexposure Prophylaxis in a Clinical Study, HIV Prevention Trials Network 073Yinfeng Zhang, William Clarke, Mark A Marzinke, et al.
Annals of Internal Medicine|August 23, 2017
Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women: A Phase 2 Randomized TrialRoy M Gulick, Timothy J Wilkin, Ying Q Chen, et al.
The Lancet. HIV|December 12, 2024
Safety, tolerability, pharmacokinetics, and neutralisation activities of the anti-HIV-1 monoclonal antibody PGT121.414.LS administered alone and in combination with VRC07-523LS in adults without HIV in the USA (HVTN 136/HPTN 092): a first-in-human, open-label, randomised controlled phase 1 trialSrilatha Edupuganti, Christopher B Hurt, Kathryn E Stephenson, et al.
Pageof 4